Masafumi Ikeda

33.8k citations
485 papers · 12.9k indexed · 6 hit papers · h-index 55
Topics
Hepatocellular Carcinoma Treatment and Prognosis (170 papers)Pancreatic and Hepatic Oncology Research (164 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (109 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaGastroenterology

In The Last Decade

Masafumi Ikeda

464 papers receiving 12.7k citations

Hit Papers

Updated efficacy and safety data fr...201420262018202220212020201420192021250500750

Peers

Masafumi Ikeda
Comparison fields: 5 of 147
  • Oncology 6.1k
  • Hepatology 5.7k
  • Surgery 3.2k
  • Epidemiology 3.0k
  • Pulmonary and Respiratory Medicine 2.8k
Replace Tim Meyer with:
Tim Meyer United Kingdom
Takuji Okusaka Japan
Robin Kate Kelley United States
Valérie Boige France
Daniel H. Palmer United Kingdom
Ho Yeong Lim South Korea
Shukui Qin China
Junji Furuse Japan
Sasan Roayaie United States
María Reig Spain
Masafumi Ikeda relative to Tim Meyer United Kingdom Tim Meyer's profile →
Citations per field
00.5×1.5×
Tim Meyer · 1×
Citations per year

Countries citing papers authored by Masafumi Ikeda

Since Specialization
Citations

This map shows the geographic impact of Masafumi Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masafumi Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masafumi Ikeda more than expected).

Fields of papers citing papers by Masafumi Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masafumi Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masafumi Ikeda. The network helps show where Masafumi Ikeda may publish in the future.

Co-authorship network of co-authors of Masafumi Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Masafumi Ikeda. A scholar is included among the top collaborators of Masafumi Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masafumi Ikeda. Masafumi Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 1
6 1
7 5
8 1
9 3
10 13
11 1
12 24
13 9
14 76
15 3
16 10
17 141
18 12
19 205
20 12

About Masafumi Ikeda

Masafumi Ikeda is a scholar working on Hepatology, Oncology and Cancer Research, having authored 485 papers that have together received 12.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (170 papers), Pancreatic and Hepatic Oncology Research (164 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (109 papers). The work is most often cited by research in Hepatology (5.7k citations), Oncology (6.1k citations) and Cancer Research (1.9k citations). Masafumi Ikeda has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Takuji Okusaka, Masatoshi Kudo, Chigusa Morizane, Hideki Ueno, Junji Furuse, Makoto Ueno, Richard S. Finn, Hiroshi Ishii, Andrew X. Zhu and Shuichi Mitsunaga. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026